相似文献
1
New approaches to establish genetic causality.
Trends Cardiovasc Med. 2015 Oct;25(7):646-52. doi: 10.1016/j.tcm.2015.02.013. Epub 2015 Mar 4.
2
Exploring predisposition and treatment response--the promise of genomics.
Prog Cardiovasc Dis. 2012 Jul-Aug;55(1):56-63. doi: 10.1016/j.pcad.2012.04.006.
3
Precision Medicine, Cardiovascular Disease and Hunting Elephants.
Prog Cardiovasc Dis. 2016 May-Jun;58(6):651-60. doi: 10.1016/j.pcad.2016.02.004. Epub 2016 Feb 21.
4
Application of Whole Exome Sequencing in the Clinical Diagnosis and Management of Inherited Cardiovascular Diseases in Adults.
Circ Cardiovasc Genet. 2017 Feb;10(1). doi: 10.1161/CIRCGENETICS.116.001573.
5
Cardiovascular genetic medicine: evolving concepts, rationale, and implementation.
J Cardiovasc Transl Res. 2008 Jun;1(2):137-43. doi: 10.1007/s12265-008-9031-3. Epub 2008 May 20.
6
Genetics and Genomics of Single-Gene Cardiovascular Diseases: Common Hereditary Cardiomyopathies as Prototypes of Single-Gene Disorders.
J Am Coll Cardiol. 2016 Dec 27;68(25):2831-2849. doi: 10.1016/j.jacc.2016.09.968.
7
Genomics of cardiovascular disease.
Mt Sinai J Med. 2009 Dec;76(6):613-23. doi: 10.1002/msj.20151.
8
Genomics of Cardiovascular Measures of Autonomic Tone.
J Cardiovasc Pharmacol. 2018 Mar;71(3):180-191. doi: 10.1097/FJC.0000000000000559.
9
Genetics of CVD in 2017: Expanding the spectrum of CVD genetics.
Nat Rev Cardiol. 2018 Feb;15(2):77-78. doi: 10.1038/nrcardio.2017.209. Epub 2017 Dec 21.
10
A Guide for a Cardiovascular Genomics Biorepository: the CATHGEN Experience.
J Cardiovasc Transl Res. 2015 Nov;8(8):449-57. doi: 10.1007/s12265-015-9648-y. Epub 2015 Aug 14.
引用本文的文献
1
Genetic and phenotypic associations of frailty with cardiovascular indicators and behavioral characteristics.
J Adv Res. 2025 May;71:263-277. doi: 10.1016/j.jare.2024.06.012. Epub 2024 Jun 9.
2
Protein haploinsufficiency drivers identify MYBPC3 variants that cause hypertrophic cardiomyopathy.
J Biol Chem. 2021 Jul;297(1):100854. doi: 10.1016/j.jbc.2021.100854. Epub 2021 Jun 5.
本文引用的文献
1
Large-scale mutational analysis of Kv11.1 reveals molecular insights into type 2 long QT syndrome.
Nat Commun. 2014 Nov 24;5:5535. doi: 10.1038/ncomms6535.
2
Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells.
Cardiovasc Res. 2014 Nov 1;104(2):258-69. doi: 10.1093/cvr/cvu205. Epub 2014 Sep 10.
3
Pathogenic variants for Mendelian and complex traits in exomes of 6,517 European and African Americans: implications for the return of incidental results.
Am J Hum Genet. 2014 Aug 7;95(2):183-93. doi: 10.1016/j.ajhg.2014.07.006. Epub 2014 Jul 31.
4
Genome editing of isogenic human induced pluripotent stem cells recapitulates long QT phenotype for drug testing.
J Am Coll Cardiol. 2014 Aug 5;64(5):451-9. doi: 10.1016/j.jacc.2014.04.057.
5
Distribution and medical impact of loss-of-function variants in the Finnish founder population.
PLoS Genet. 2014 Jul 31;10(7):e1004494. doi: 10.1371/journal.pgen.1004494. eCollection 2014 Jul.
6
Guidelines for investigating causality of sequence variants in human disease.
Nature. 2014 Apr 24;508(7497):469-76. doi: 10.1038/nature13127.
7
PredictSNP: robust and accurate consensus classifier for prediction of disease-related mutations.
PLoS Comput Biol. 2014 Jan;10(1):e1003440. doi: 10.1371/journal.pcbi.1003440. Epub 2014 Jan 16.
8
Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome.
EMBO J. 2013 Dec 11;32(24):3161-75. doi: 10.1038/emboj.2013.240. Epub 2013 Nov 8.
9
Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
Circ Cardiovasc Genet. 2013 Dec;6(6):557-68. doi: 10.1161/CIRCGENETICS.113.000188. Epub 2013 Nov 7.
10
Actionable, pathogenic incidental findings in 1,000 participants' exomes.
Am J Hum Genet. 2013 Oct 3;93(4):631-40. doi: 10.1016/j.ajhg.2013.08.006. Epub 2013 Sep 19.
Zotero 插件